The Asia-Pacific veterinary vaccines market is set to project a CAGR of 8.69% during the forecast period, 2022-2030, garnering a revenue of $3288.56 million by 2030.

ASIA-PACIFIC VETERINARY VACCINES MARKET FORECAST 2022-2030

Asia-Pacific Veterinary Vaccines Market by Animal Type (Livestock Animal, Companion Animal, Aquaculture) Market by Product Type (Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vaccines, Subunit Vaccines) Market by Disease Type (Canine Disease, Porcine Disease, Bovine Disease, Poultry Disease, Aquaculture Disease, Other Diseases) by Geography

Request free sample

Report Summary

The Asia-Pacific veterinary vaccines market is set to project a CAGR of 8.69% during the forecast period, 2022-2030, garnering a revenue of $3288.56 million by 2030.

Asia houses the world’s largest number of livestock like poultry & fish, pigs, cattle, facilitating growth opportunities for several veterinary vaccine market players. Also, in May 2021, the Southeast Asian Nations (ASEAN) and the World Organization for Animal Health (OIE) signed a new Memorandum of Understanding (MoU) for enhanced cooperation and support for restricting, eradicating, and preventing animal diseases in South-East Asia.

To know more about this report, request a free sample copy

The Asia-Pacific veterinary vaccines market growth assessment includes the growth evaluation of South Korea, India, Japan, China, Thailand, Vietnam, Australia & New Zealand, Indonesia, and Rest of Asia-Pacific. China has around 95 million cattle units. Also, the consumption of meat and dairy products is high in the country. The country has an almost 415.9 million pig population, making it the largest pork producer globally. Subsequently, such a large livestock population requires extreme care and protection from several diseases to further avoid losses in terms of revenue. Therefore, China is evaluated as a key market for veterinary manufacturing companies. Moreover, veterinary pharmaceuticals are scaling and expanding their businesses such countries in Asia. Additionally, the country has the presence of several eminent regional players.

South Korea’s cattle population is almost 3.5 million, and its pig population is around 11 million. Such animal types are subject to a high risk of Foot and Mouth Disease (FMD). As a result, the Animal and Plant quarantine Agency has developed a new adjuvant for FMD vaccines. This multi-purpose agent induces long-term immunity and stimulates immune cells at the introductory stage of vaccination with immense immune defense against the FMD virus. Such developments are favorable to the market growth in South Korea.

In Indonesia, the livestock cattle population stands at 17.4 million, poultry at 30 million, and swine at 8.5 million. Also, animal producers are prioritizing the health and disease prevention of their cattle, given the increasing importance of animal husbandry in meat, dairy, and milk production. In addition, the market is benefited by the domestic companies involved in animal vaccine manufacturing and distribution competing with international firms.

The Asia-Pacific veterinary vaccines market’s segmentation analysis includes animal type, product type, and disease type. The disease type category is sub-segmented into aquaculture disease, poultry disease, bovine disease, canine disease, porcine disease, and other diseases. Canine diseases are diagnosed in dogs and other related species. Some common canine diseases are Lyme disease, giardia, parainfluenza, rabies, and canine distemper. Dogs are the increasingly-adopted or most-domesticated canines globally. Also, they are at increased risk of such diseases. As a result, this is a potential segment to capitalize for veterinary vaccine manufacturers.

Some of the leading players in the Asia-Pacific veterinary vaccines market are HIPRA, Indian Immunologicals Limited, Merck Animal Health, Phibro Animal Health, etc.

Indian Immunologicals Limited supplies animal health vaccines to over 50 countries worldwide. The Animal Health Division of the company offers a variety of therapeutic products for companion and livestock animals to improve their reproductive and productive status. The product portfolio includes nutraceuticals, formulations, and vaccines. The company operates in Russia, Africa, Latin America, the Middle East, Asia, and CIS countries, with headquarters in Hyderabad, India.

One of its key products includes Bruvax Plus, recommended for prophylactic vaccination against Brucellosis in non-lactating & non-pregnant animals and female calves.

Report Synopsis

Report Scope	Details
Market Forecast Years	2022-2030
Base Year	2021
Market Historical Years	2018-2021
Forecast Units	Revenue (Million)
Segments Analyzed	Product Type, Animal Type, Disease Type
Countries Analyzed	South Korea, India, Japan, China, Thailand, Vietnam, Australia & New Zealand, Indonesia, and Rest of Asia-Pacific
Companies Analyzed	Boehringer Ingelheim International GmbH, Brilliant Bio Pharma, Ceva Sante Animale, Elanco Animal Health, Hester Biosciences Ltd, Hipra, Indian Immunologicals Limited, Merck Animal Health, Phibro Animal Health, Vaxxinova GmbH, Virbac SA, and Zoetis

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
MARKET DYNAMICS
- KEY DRIVERS
  - RESEARCH & DEVELOPMENT OF ADVANCED VACCINES
  - NEED OF VACCINE DUE TO RISING ANIMAL POPULATION AND DISEASES
  - VACCINATION DRIVES BY GOVERNMENT AGENCIES
- KEY RESTRAINTS
  - RULES & REGULATIONS FOR THE USE OF VACCINE
  - LACK OF AWARENESS AMONG FARMERS AND REQUIREMENT OF SKILLED VETERINARIANS

KEY ANALYTICS
- IMPACT OF COVID-19 ON VETERINARY VACCINES MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
  - BUYERS POWER
  - SUPPLIERS POWER
  - SUBSTITUTION
  - NEW ENTRANTS
  - INDUSTRY RIVALRY
- VALUE CHAIN ANALYSIS
- KEY BUYING CRITERIA
- REGULATORY FRAMEWORK
MARKET BY ANIMAL TYPE
- LIVESTOCK ANIMAL
  - CATTLE
  - PIGS
  - POULTRY
  - SHEEP
  - OTHER LIVESTOCK ANIMALS
- COMPANION ANIMAL
  - CANINE
  - FELINE
  - EQUINE
- AQUACULTURE
MARKET BY PRODUCT TYPE
- ATTENUATED VACCINES
- INACTIVATED VACCINES
- TOXOID VACCINES
- CONJUGATE VACCINES
- DNA VACCINES
- RECOMBINANT VACCINES
- SUBUNIT VACCINES
MARKET BY DISEASE TYPE
- CANINE DISEASE
- PORCINE DISEASE
- BOVINE DISEASE
- POULTRY DISEASE
- AQUACULTURE DISEASE
- OTHER DISEASES
GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - CHINA
    - JAPAN
    - INDIA
    - SOUTH KOREA
    - INDONESIA
    - THAILAND
    - VIETNAM
    - AUSTRALIA & NEW ZEALAND
    - REST OF ASIA-PACIFIC

COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
  - MERGERS & ACQUISITIONS
  - PRODUCT LAUNCHES & DEVELOPMENTS
  - PARTNERSHIPS & AGREEMENTS
  - BUSINESS EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
  - BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  - BRILLIANT BIO PHARMA
  - CEVA SANTE ANIMALE
  - ELANCO ANIMAL HEALTH
  - HESTER BIOSCIENCES LTD
  - HIPRA
  - INDIAN IMMUNOLOGICALS LIMITED
  - MERCK ANIMAL HEALTH
  - PHIBRO ANIMAL HEALTH
  - VAXXINOVA GMBH
  - VIRBAC SA
  - ZOETIS

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – VETERINARY VACCINES

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 4: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COMPANION ANIMAL TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COMPANION ANIMAL TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DISEASE TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DISEASE TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15: LEADING PLAYERS OPERATING IN ASIA-PACIFIC VETERINARY VACCINES MARKET

TABLE 16: LIST OF MERGERS & ACQUISITIONS

TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 19: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: VALUE CHAIN ANALYSIS

FIGURE 4: KEY BUYING CRITERIA

FIGURE 5: ASIA-PACIFIC VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY ANIMAL TYPE, IN 2021

FIGURE 6: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMAL, 2022-2030 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY LIVESTOCK ANIMAL, IN 2021

FIGURE 8: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CATTLE, 2022-2030 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PIGS, 2022-2030 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY POULTRY, 2022-2030 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY SHEEP, 2022-2030 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2030 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COMPANION ANIMAL, 2022-2030 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY COMPANION ANIMAL TYPE, IN 2021

FIGURE 15: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CANINE, 2022-2030 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY FELINE, 2022-2030 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY EQUINE, 2022-2030 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2030 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021

FIGURE 20: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 22: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 23: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 25: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 26: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2030 (IN $ MILLION)

FIGURE 27: ASIA-PACIFIC VETERINARY VACCINES MARKET, GROWTH POTENTIAL, BY DISEASE TYPE, IN 2021

FIGURE 28: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 29: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 30: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 31: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 32: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2030 (IN $ MILLION)

FIGURE 33: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY OTHER DISEASES, 2022-2030 (IN $ MILLION)

FIGURE 34: ASIA-PACIFIC VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 35: CHINA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 36: JAPAN VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 37: INDIA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 38: SOUTH KOREA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 39: INDONESIA VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 40: THAILAND VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 41: VIETNAM VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: AUSTRALIA & NEW ZEALAND VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: REST OF ASIA-PACIFIC VETERINARY VACCINES MARKET, 2022-2030 (IN $ MILLION)

SEGMENTATION

GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - CHINA
    - JAPAN
    - INDIA
    - SOUTH KOREA
    - INDONESIA
    - THAILAND
    - VIETNAM
    - AUSTRALIA & NEW ZEALAND
    - REST OF ASIA-PACIFIC

MARKET BY ANIMAL TYPE
- LIVESTOCK ANIMAL
  - CATTLE
  - PIGS
  - POULTRY
  - SHEEP
  - OTHER LIVESTOCK ANIMALS
- COMPANION ANIMAL
  - CANINE
  - FELINE
  - EQUINE
- AQUACULTURE
MARKET BY PRODUCT TYPE
- ATTENUATED VACCINES
- INACTIVATED VACCINES
- TOXOID VACCINES
- CONJUGATE VACCINES
- DNA VACCINES
- RECOMBINANT VACCINES
- SUBUNIT VACCINES
MARKET BY DISEASE TYPE
- CANINE DISEASE
- PORCINE DISEASE
- BOVINE DISEASE
- POULTRY DISEASE
- AQUACULTURE DISEASE
- OTHER DISEASES